A Phase I/II Study to Evaluate XNW34017 in Patients With Advanced or Metastatic Solid Tumor

Clinical trial NCT07327294 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07327294
Sponsor: Evopoint Biosciences Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2026-01-31
Primary completion: 2027-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.